Merck & Co., Inc. (MRK)
148.95
+1.19
(+0.81%)
USD |
NYSE |
Sep 01, 12:21
Merck Research and Development Expense (Annual) : 12.51B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 12.51B |
| December 31, 2024 | 15.79B |
| December 31, 2023 | 30.53B |
| December 31, 2022 | 11.82B |
| December 31, 2021 | 10.21B |
| December 31, 2020 | 9.126B |
| December 31, 2019 | 8.664B |
| December 31, 2018 | 9.598B |
| December 31, 2017 | 9.845B |
| December 31, 2016 | 5.975B |
| December 31, 2015 | 6.573B |
| December 31, 2014 | 6.532B |
| December 31, 2013 | 7.123B |
| December 31, 2012 | 7.911B |
| December 31, 2011 | 7.742B |
| December 31, 2010 | 8.163B |
| December 31, 2009 | 5.613B |
| December 31, 2008 | 4.677B |
| December 31, 2007 | 4.558B |
| December 31, 2006 | 3.964B |
| December 31, 2005 | 3.829B |
| December 31, 2004 | 3.885B |
| December 31, 2003 | 3.178B |
| Date | Value |
|---|---|
| December 31, 2002 | 2.677B |
| December 31, 2001 | 2.456B |
| December 31, 2000 | 2.344B |
| December 31, 1999 | 2.068B |
| December 31, 1998 | 1.821B |
| December 31, 1997 | 1.684B |
| December 31, 1996 | 1.487B |
| December 31, 1995 | 1.331B |
| December 31, 1994 | 1.231B |
| December 31, 1993 | 1.173B |
| December 31, 1992 | 1.112B |
| December 31, 1991 | 987.80M |
| December 31, 1990 | 854.00M |
| December 31, 1989 | 750.50M |
| December 31, 1988 | 668.80M |
| December 31, 1987 | 565.70M |
| December 31, 1986 | 479.80M |
| December 31, 1985 | 426.26M |
| December 31, 1984 | 393.12M |
| December 31, 1983 | 356.04M |
| December 31, 1982 | 320.16M |
| December 31, 1981 | 274.17M |
| December 31, 1980 | 233.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |
| Bristol Myers Squibb Co. | 9.492B |
| Abbott Laboratories | 2.889B |